Man Group’s G1 Therapeutics GTHX Stock Holding History
Bought
Maintained
Sold
Man Group's GTHX Position: Q3 2024 in Review
Man Group sold out of G1 Therapeutics (GTHX) in Q3 2024, closing a stake of 127,723 shares — an estimated $291K sold.
Man Group first reported a position in GTHX in Q3 2020 and held it in 7 quarters. The position peaked at $1.74M in Q4 2020. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Man Group reported no remaining G1 Therapeutics position as of Q3 2024 after selling out during the quarter.
- Man Group sold 127,723 G1 Therapeutics shares in Q3 2024, an estimated $291K.
- Man Group first reported a position in G1 Therapeutics in Q3 2020 and held it in 7 quarters.
- Man Group's G1 Therapeutics position peaked at $1.74M in Q4 2020.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics as of Q3 2024.
Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.